by Rikki Almanza | Aug 12, 2026
The VA has launched a clinical trial to study whether psilocybin can safely help Veterans with major depression that has not responded to conventional treatment, including those who also have PTSD. The study was announced Aug. 5 under the name Psilocybin Intervention...
by Rikki Almanza | Aug 3, 2026
The VA has launched a nationwide clinical trial to determine whether a GLP-1 drug can help Veterans reduce harmful alcohol use. Semaglutide is a GLP-1 medication commonly prescribed for type 2 diabetes and obesity. Researchers are studying whether the drug may also...
by Rikki Almanza | Jul 10, 2026
A new survey from RAND shows a clear divide among Veterans on psychedelics, with views changing depending on the substance and how it would be used. The report, “U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences,” estimates that about 4.8...
by Rikki Almanza | Jun 15, 2026
The VA is preparing a new study that will examine whether MDMA-assisted therapy may be safe and useful for Veterans who are dealing with both post-traumatic stress disorder and alcohol use disorder. The research will focus on MDMA, or methylenedioxymethamphetamine,...
